Cameron Turtle, CEO: Spyre Therapeutics SYRE Sell · Filed 04/03

Trade details

Type: Insider sale
Amount: $607,324.8
Shares · price: 12,344 sh · $49.20 a share
Held after: 630,196 sh
Stock: Spyre Therapeutics SYRE
Person: Cameron TurtleCEO
Trade date: 26/04/01
Filed: 26/04/03
Days to filing: 2 days

Sold 1.9% of holdings

Share of holding sold: 1.9%

Spyre Therapeutics trades, last 26 weeks

What else happened in Spyre Therapeutics around then

Filed or reported within 30 days of the trade day · 03/02~05/01

Cameron Turtle's recent trades

Cameron TurtleCEO
Planned sale10b5-1 planSpyre Therapeutics
Planned sale10b5-1 plan
Spyre Therapeutics
SYRE
$4M
45,000 sh
$4M
Filed 07/01
Traded 07/01
Cameron TurtleCEO
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$574.5K
8,149 sh
$574.5K
Filed 06/03
Traded 06/01
Cameron TurtleCEO
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$246.9K
3,557 sh
$246.9K
Filed 06/03
Traded 06/01
Cameron TurtleCEO
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$235.1K
3,294 sh
$235.1K
Filed 06/03
Traded 06/01
Cameron TurtleCEO
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$368.6K
5,300 sh
$368.6K
Filed 05/01
Traded 05/01